Literature DB >> 3498589

C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.

S Uwatoko1, S Aotsuka, M Okawa, Y Egusa, R Yokohari, C Aizawa, K Suzuki.   

Abstract

In earlier studies we showed that the C1q-binding IgG in the sera from patients with systemic lupus erythematosus (SLE) tested by C1q solid-phase radioimmunoassay is cofractionated with monomeric IgG on gel filtration and mostly binds to C1q via the F(ab')2 region. In this study, we found that C1q, even when stripped of its immune complex-binding globular regions by pepsin digestion, retained a substantial part of its ability to bind IgG from SLE sera, suggesting that the collagen-like region of C1q is involved in binding to the SLE IgG. Heat-inactivation of C1q also failed to abolish its ability to bind IgG from SLE sera. In contrast, the binding of C1q to heat-aggregated IgG was completely abrogated by these treatments. In addition, the reaction of heat-aggregated IgG with the solid-phase C1q was markedly dependent on ionic strength whereas the binding of IgG from SLE sera with the solid-phase C1q persisted at high concentrations of salt. These findings suggest that the Clq-binding IgG in SLE sera is, at least in part, antibody directed against the collagen-like region of C1q.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498589      PMCID: PMC1542256     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Subunit composition and structure of subcomponent C1q of the first component of human complement.

Authors:  K B Reid; R R Porter
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

2.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent Clq of the first component of human complement.

Authors:  K B Reid
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

4.  Enzymatic digestion of the first component of human complement (C1q).

Authors:  H R Knobel; C Heusser; M L Rodrick; H Isliker
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

5.  Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera.

Authors:  K B Reid; D M Lowe; R R Porter
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

6.  Ultrastructure of the human complement component, Clq (negative staining-glutamine synthetase-biologically active Clq).

Authors:  E Shelton; K Yonemasu; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

7.  Fixation of C' and C'la by rabbit gamma-G- and gamma-M-antibodies with particulate and soluble antigens.

Authors:  T Ishizaka; T Tada; K Ishizaka
Journal:  J Immunol       Date:  1968-06       Impact factor: 5.422

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Heat-polymerization of human immunoglobulin G.

Authors:  R Yokohari; K Takeda; Y Imamura
Journal:  Immunochemistry       Date:  1973-09

10.  C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum.

Authors:  A T Sobel; V A Bokisch; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Autoantibodies against C1q: view on clinical relevance and pathogenic role.

Authors:  C E Siegert; M D Kazatchkine; A Sjöholm; R Würzner; M Loos; M R Daha
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Antibodies against C1q in anti-glomerular basement membrane nephritis.

Authors:  I E Coremans; M R Daha; E A van der Voort; Y Muizert; C Halma; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

3.  Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.

Authors:  S Uwatoko; M Mannik
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

4.  Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.

Authors:  Leendert A Trouw; Tom W L Groeneveld; Marc A Seelen; Jacques M G J Duijs; Ingeborg M Bajema; Frans A Prins; Uday Kishore; David J Salant; J Sjef Verbeek; Cees van Kooten; Mohamed R Daha
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

5.  Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.

Authors:  C E Siegert; M R Daha; C M Tseng; I E Coremans; L A van Es; F C Breedveld
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

6.  IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus.

Authors:  C E Siegert; M R Daha; S Lobatto; E A van der Voort; F C Breedveld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 7.  The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.

Authors:  Federica Defendi; Nicole M Thielens; Giovanna Clavarino; Jean-Yves Cesbron; Chantal Dumestre-Pérard
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

Review 8.  Complement components and their autoantibodies.

Authors:  P Norsworthy; K A Davies
Journal:  Mol Biotechnol       Date:  2003-03       Impact factor: 2.860

9.  Anti-C1q autoantibodies, novel tests, and clinical consequences.

Authors:  Michael Mahler; Rosanne A van Schaarenburg; Leendert A Trouw
Journal:  Front Immunol       Date:  2013-05-14       Impact factor: 7.561

Review 10.  Complement and systemic lupus erythematosus.

Authors:  Mark J Walport
Journal:  Arthritis Res       Date:  2002-05-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.